BamSEC and AlphaSense Join Forces
Learn More

PLUS THERAPEUTICS Inc.

NASDAQ: PSTV    
Share price (11/21/24): $1.20    
Market cap (11/21/24): $7.076 million
Search in Documents
Key Exhibits
External Links

Indentures Filter

EX-4.11
from S-3 55 pages Indenture Dated as of , 20 Between PLUS Therapeutics, Inc. as Issuer, and as Trustee Providing for Issuance of Debt Securities in Series
12/34/56
EX-4.8
from 10-Q 5 pages Amendment and Restatement of the Plus Therapeutics, Inc. Series B Common Stock Purchase Warrant
12/34/56
EX-4.7
from 10-Q 5 pages Amendment and Restatement of the Plus Therapeutics, Inc. Series a Common Stock Purchase Warrant
12/34/56
EX-4.6
from 10-Q 17 pages Form of Series B Common Stock Purchase Warrant Plus Therapeutics, Inc
12/34/56
EX-4.5
from 10-Q 17 pages Form of Series a Common Stock Purchase Warrant Plus Therapeutics, Inc
12/34/56
EX-4.3
from 8-K 17 pages Form of Series B Common Stock Purchase Warrant Plus Therapeutics, Inc
12/34/56
EX-4.2
from 8-K 17 pages Form of Series a Common Stock Purchase Warrant Plus Therapeutics, Inc. Warrant Shares: Issue Date: May ___, 2024
12/34/56
EX-4.1
from 8-K 13 pages Pre-Funded Common Stock Purchase Warrant Plus Therapeutics, Inc
12/34/56
EX-4.1
from S-3 49 pages Plus Therapeutics, Inc. to [] Trustee Indenture Dated as Of, 20 Plus Therapeutics, Inc. Reconciliation and Tie Between Trust Indenture Act of 1939 and Indenture, Dated as Of, 20
12/34/56
EX-4.1
from 8-K 6 pages Form of Underwriter Warrant Amendment Agreement
12/34/56
EX-4.1
from 8-K 6 pages Form of Warrant Amendment Agreement
12/34/56
EX-4.1
from 10-K 3 pages Description of the Company’s Securities Registered Under Section 12 of the Exchange Act of 1934
12/34/56
EX-4.38
from S-1/A 20 pages Series V Prefunded Common Stock Purchase Warrant Plus Therapeutics, Inc
12/34/56
EX-4.37
from S-1/A 20 pages Series U Common Stock Purchase Warrant Plus Therapeutics, Inc
12/34/56
EX-4
from POS AM 27 pages Warrant Agent Agreement
12/34/56
EX-4
from POS AM 4 pages Form of Non-Transferable Subscription Rights Certificate
12/34/56
EX-4
from POS AM 6 pages This Warrant Shall Be Void if Not Exercised Prior to the Expiration of the Exercise Period Provided for in the Warrant Agreement Described Below Cytori Therapeutics, Inc. Incorporated Under the Laws of the State of Delaware Cusip [ ] Series T Warrant Certificate
12/34/56
EX-4
from S-1/A 24 pages Warrant Agent Agreement
12/34/56
EX-4
from S-1/A 4 pages Form of Non-Transferable Subscription Rights Certificate
12/34/56
EX-4
from S-1/A 5 pages This Warrant Shall Be Void if Not Exercised Prior to the Expiration of the Exercise Period Provided for in the Warrant Agreement Described Below Cytori Therapeutics, Inc. Incorporated Under the Laws of the State of Delaware Cusip [ ] Series T Warrant Certificate
12/34/56